RTI Biologics Launches BioAdapt DBM Foam

RTI Biologics, an Alachua, Fla.-based orthopedic device company, has launched the BioAdapt DBM Foam, a flexible demineralized bone matrix solution, according to a company news release.

Advertisement

BioAdapt offers five pre-shaped options to match the bone grafting needs of trauma, reconstructive, spine and extremities cases. The solution is designed to expand with hydration and can adapt to the contours of the surgical site.

Read the release about BioAdapt.

Related Articles on RTI Biologics:

RTI Biologics Develops Reimbursement Hotline for Sports Medicine

RTI Pays $3M for Athersys Orthopedic Implant Technology
RTI Biologics Reports 4Q Revenue at $45.4M, 8% Increase

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.